Literature DB >> 10401924

SSRI-induced parkinsonism may be an early sign of future Parkinson's disease.

A S Gönül, M Aksu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10401924     DOI： 10.4088/jcp.v60n0611d

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  5 in total

1.  A Case of SSRI Induced Irreversible Parkinsonism.

Authors:  Siddharth Dixit; Shahbaj A Khan; Sudip Azad
Journal:  J Clin Diagn Res       Date:  2015-02-01

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

3.  Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors.

Authors:  Hamdolah Sharifi; Alireza Mohajjel Nayebia; Safar Farajnia
Journal:  Adv Pharm Bull       Date:  2013-02-07

4.  Parkinsonism secondary to duloxetine use: a case report.

Authors:  Arzu Bayrak; Bugra Cetin; Handan Meteris; Sermin Kesebir
Journal:  North Clin Istanb       Date:  2015-12-25

Review 5.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.